Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
104.04
+1.62 (1.58%)
Aug 25, 2026, 11:11 AM EDT - Market open
Oruka Therapeutics Employees
Oruka Therapeutics had 68 employees as of December 31, 2025. The number of employees increased by 40 or 142.86% compared to the previous year.
Employees
68
Change (1Y)
40
Growth (1Y)
142.86%
Revenue / Employee
n/a
Profits / Employee
-$1,613,059
Market Cap
6.89B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 68 | 40 | 142.86% |
| Dec 31, 2024 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| ImmunityBio | 691 |
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 433 |
| Rhythm Pharmaceuticals | 414 |
| TG Therapeutics | 399 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
ORKA News
- 19 hours ago - Oruka Therapeutics appoints Todd Edwards as chief commercial officer - TheFly
- 19 hours ago - Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer - GlobeNewsWire
- 3 days ago - Oruka Therapeutics files $1B mixed securities shelf - TheFly
- 4 days ago - Oruka Therapeutics Registration statement: Registration filing - Filings
- 15 days ago - Oruka Therapeutics reports Q2 EPS (55c), consensus (50c) - TheFly
- 15 days ago - Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire
- 15 days ago - Oruka Therapeutics Earnings release: Q2 2026 - Filings
- 15 days ago - Oruka Therapeutics Quarterly report: Q2 2026 - Filings